• Home
  • News
    • Editorial
    • MD(e)B(unker)
    • Related Researches
      • Di Bella's Foundation
      • 1960-1969
      • 1970-1979
      • 1980-1989
      • 1990-1999
      • 2000-2009
      • 2010-2019
      • 2020-2029
    • Science news
    • Scientific Documentation
  • About us...
    • Biography
    • Bibliography
  • The Method
    • Di Bella's Method!
    • 1998 Trial!
  • Media
    • Video Publications
    • News-PapersNews-Papers
      • Press
    • TestimonialTestimonial
      • Testimonies
    • Video GalleryVideo Gallery
      • Congresses
      • Video Testimonies
      • TV & C.
  • Case History
    • Medical reports
      • Lung
      • Lymphomas
        • Non-Hodgkin Lymphomas
        • Hodgkin Lymphomas
      • Mediastinum
      • Mesothelioma
      • Myeloma
      • Pancreas
      • Scientific Publications
  • F.A.Q.
  • Useful Links
    • User Side
      • Vademecum
    • CouponChief - Resources for Cancer Patients
  • Contact Us
Home page   News   Related Researches   1990-1999  
Title Created Date
Effects of melatonin on mammary gland lesions in transgenic mice overexpressing N-ras proto-oncogene 25 April 2018
Somatostatin-receptor scintigraphy in primary breast cancer 20 April 2018
A human prolactin antagonist, hPRL-G129R, inhibits breast cancer cell proliferation through induction of apoptosis 17 April 2018
Plasma prolactin in patients with colorectal cancer. Value in follow-up and as a prognosticator 16 April 2018
Expression of somatostatin receptors in normal, inflamed, and neoplastic human gastrointestinal tissues 13 April 2018
Melatonin's inhibitory effect on growth of ME-180 human cervical cancer cells is not related to intracellular glutathione concentrations 03 April 2018
Tumor-suppressive effect of the retinoic acid receptor beta in human epidermoid lung cancer cells 30 March 2018
Somatostatin receptors in human renal cell carcinomas 29 March 2018
Inhibition of growth of prostatic cancer cell lines by peptide analogues of insulin-like growth factor 1 28 March 2018
Somatostatin-14 mainly binds the somatostatin receptor subtype 2 in human neuroblastoma tumors 22 March 2018
Display # 

Page 27 of 60

  • Start
  • Prev
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • Next
  • End

Search

Follow us...

Latest

  • Melatonin and breast cancer: cellular mechanisms, clinical studies and future perspectives
  • Melatonin in cancer management: progress and promise
  • Radioprotective effect of melatonin on the cervical spinal cord in irradiated rats
  • Protective effects of melatonin and vitamin E in brain damage due to gamma radiation: an experimental study
  • Melatonin in Cancer Treatment: Current Knowledge and Future Opportunities
  • The impact of vitamin D on cancer: A mini review
  • Retinoic acid receptor activation reprograms senescence response and enhances anti-tumor activity of natural killer cells
  • Radio-Protective Effects of Melatonin on Subventricular Zone in Irradiated Rat: Decrease in Apoptosis and Upregulation of Nestin
  • Modulating effects of famotidine and melatonin on high dose radiation induced cell lethality in normal human and cancer cell lines
  • Melatonin Sensitizes Human Colorectal Cancer Cells to γ-ray Ionizing Radiation In Vitro and In Vivo
  • Melatonin: an endogenous miraculous indolamine, fights against cancer progression
  • Melatonin: An Endogenous Antiestrogen with Oncostatic Properties
  • Benefits of short-chain fatty acids and their receptors in inflammation and carcinogenesis
  • Disease Control after Androgen Deprivation Therapy Combined with Di Bella Multitherapy
  • Somatostatin and Somatostatin Receptors in Tumour Biology
  • Growth Hormone Action as a Target in Cancer: Significance, Mechanisms, and Possible Therapies
  • Immunohistochemical expression and localization of somatostatin receptor subtypes in prostate cancer with neuroendocrine differentiation
  • Androgen Receptor Regulation of Local Growth Hormone in Prostate Cancer Cells

Most Read

  • The Di Bella Method (DBM)
  • About melatonin - 1996
  • All-trans-retinoic acid and cancer
  • Biography
  • Chronic Lymphocytic Leukemia: 4 patients, long-lasting remission
  • The Di Bella Method Increases by the 30% the survival rate for Pancreas tumors and for this reason should be proposed as first line therapy for this type of cancer
  • Somatostatin in oncology, the overlooked evidences
  • Treatment of Low-grade Non-Hodgkin’s Lymphomas at Advanced Stage
  • How effective is chemo therapy?
  • Complete objective response to biological therapy of plurifocal breast carcinoma
  • Bibliography
  • Large B-cells Non-Hodgkin's Lymphoma, Stage IV-AE: a Case Report
  • Non-Hodgkin's Lymphoma, Stage III-B-E: a Case Report
  • Vademecum
  • Frequently Asked Questions
  • Declaration recommends eliminate the use of Impact factor for research evaluation
  • Non–Small-Cell Lung Cancer Patients with Low Performance Status: study on 28 patients
  • Breast cancer: study on 122 cases. The Di Bella Method (DBM) improved survival, objective response and performance status in a retrospective observational clinical study on 122 cases of breast cancer